Retatrutide

What Is Retatrutide?

Retatrutide is a next-generation triple agonist acting simultaneously on GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors. It represents an advanced analytical reference compound for researchers studying multi-receptor metabolic pathway interactions in in-vitro laboratory models.

VELTRIDE supplies Retatrutide at ≥99% HPLC purity with a Certificate of Analysis available for every lot, shipped discreetly Canada-wide. For in-vitro research use only. Not for human consumption.

Research Applications

Key areas of in-vitro research using Retatrutide as a reference standard include:

• Triple GIP/GLP-1/glucagon receptor co-activation mechanism studies
• Multi-receptor agonism and downstream cAMP/PKA signaling pathway research
• Advanced metabolic pathway modeling and comparative analysis
• Comparative pharmacodynamic studies with mono and dual agonist reference standards
• Hepatic glucose production regulation research in cell culture models
• Energy homeostasis pathway research in vitro
• Next-generation receptor agonist characterization studies

Certificate of Analysis

Storage & Handling

• Store lyophilized powder at −20°C in a sealed, dry environment
• Protect from light and moisture at all times
• Reconstitute with appropriate research-grade buffer for in-vitro use
• Handle with appropriate laboratory PPE (gloves, eye protection)
• For in-vitro research use only — not for administration to humans or animals